Bafiertam, a novel fumarate, is indicated for the treatment of patients with relapsing
forms of multiple sclerosis.
Early age at debut is a predictor of steroid-dependent and frequent relapsing
Although Colby was still under the care of a doctor and at risk for relapsing
back into her addiction to Fentanyl, the insurance company said a "risk for relapse is not the same as a current disability."
Patients completing Part 1 of ARMS questionnaire (N = 103) Age, years, mean (SD) 42.5 (11.2) Sex, n (%) Male 14 (14) Female 89 (86) Type of MS, n (%) (n = 97 *) RRMS 95 (98) SPMS 2(2) ARMS: Assessing Relapse in Multiple Sclerosis; SD: standard deviation; RRMS: relapsing
remitting MS; SPMS: secondary progressive MS.
Brooks and McHenry (2009) stated that "relapsing
clients generally have a multitude of issues that can combine to sabotage their recovery efforts" (p.
Hence it was concluded that the daily administration of maintenance doses of prednisolone, during intercurrent infections, significantly reduces relapse rates and the proportion of children with frequently relapsing
The high recidivism rates of substance use disorders are well known (Marlatt & Gordon 1985), and substance use disorders have been referred to as chronic relapsing
patients in this study population were more likely to have achieved only a primary level of education.
Currently, rituximab (Rituxan), a laboratory-engineered antibody that marks antibody producing cells for destruction, is being studied and evaluated for safety for use in people with progressive and relapsing
forms of MS.
fever Borrelia infections have attracted little attention in recent years; however, where endemic, these infections still result in considerable illness and death.
(4) Most patients who initially have Guillain-Barre syndrome are children, and children are more likely than adults to have a relapsing
and quickly fluctuating form of the disease.
Results from the largest clinical trial ever completed in Relapsing
Multiple Sclerosis (RMS) have shown that AVONEX (Interferon beta-1a) administered at doses of 30 mcg and 60 mcg IM once weekly are equally effective in reducing disability progression -- the primary end point of the study.